Our earlier reports demonstrated the usefulness of anti-prothrombin antibodies (aPT) in the diagnosis of APS in SLE patients and the highest specificity showed aPT IgG (95.12%). This evidence concerns the gene LYPLA2P1 and systemic lupus erythematosus.